<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01007331</url>
  </required_header>
  <id_info>
    <org_study_id>KF-D200 Prob√∏rn</org_study_id>
    <nct_id>NCT01007331</nct_id>
  </id_info>
  <brief_title>Probiotic Bacteria to Infants With Atopic Dermatitis</brief_title>
  <official_title>Probiotic Bacteria to Infants With Atopic Dermatitis; an Investigation of the Effect on Eczema, Immunologic Status and the Intestinal Microflora, Inflammation and Permeability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to examine whether 8 weeks intervention with probiotics
      influence the eczema in infants suffering from Atopic Dermatitis. Furthermore the influence
      of the immunologic status and the intestinal microflora, inflammation and permeability will
      be investigated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to investigate whether two different probiotics influence the
      clinical and subjective symptoms in infants with Atopic Dermatitis (AD). The influence on the
      immunologic status and the intestinal microflora, inflammation and permeability will also be
      investigated.

      Sixty two infants (6 to 24 months of age) suffering from AD will be randomised in 3 groups
      receiving either Lactobacillus acidophilus NCFM (1x10^10 Colony forming units),
      Bifidobacterium lactis Bi-07(1x10^10 Colony forming units) or placebo every day for 8 weeks.

      At the beginning and at the end of the study the following analyses will be made:

        1. SCORing Atopic Dermatitis (SCORAD) index to describe the extent and severity of the
           eczema, and to describe the subjective symptoms.

        2. Blood samples will be drawn to examine:

             -  Immunoglobulin E (IgE), total and specific for egg and milk.

             -  Eosinophil Cation Protein (ECP)

             -  Interleukin-10 (Il-10), Interleukin-12 (Il-12) and Interferon-gamma (IFN-gamma)

        3. Fecal samples will be collected to examine:

             -  Calprotectin (intestinal inflammation)

             -  Bacterial Deoxyribonucleic acid (DNA) will be extracted in order to perform
                Polymerase chain reaction (PCR) analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Scoring atopic dermatitis (SCORAD) index</measure>
    <time_frame>5 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immunoglobulin E (IgE) Total</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunoglobulin E (IgE) specific for Egg</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunoglobulin E (IgE) specific for Milk</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-10 (Il-10)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin-12 (Il-12)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interferon gamma (IFN-gamma)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calprotectin</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polymerase Chain Reaction (PCR)</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Eosinophil Cation Protein (ECP)</measure>
    <time_frame>7 months</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">62</enrollment>
  <condition>Atopic Dermatitis</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07</intervention_name>
    <description>10^10 colony forming units pr day of probiotics</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Atopic dermatitis

        Exclusion Criteria:

          -  Chronic diseases other than atopic dermatitis

          -  Chronic medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kim F Michaelsen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Human Nutrition, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Human Nutrition</name>
      <address>
        <city>Rolighedsvej 30</city>
        <state>Frederiksberg C</state>
        <zip>1958</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2009</study_first_submitted>
  <study_first_submitted_qc>November 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2009</study_first_posted>
  <last_update_submitted>February 16, 2010</last_update_submitted>
  <last_update_submitted_qc>February 16, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2010</last_update_posted>
  <responsible_party>
    <name_title>Kim Fleischer Michaelsen</name_title>
    <organization>Department of Human Nutrition, University of Copenhagen</organization>
  </responsible_party>
  <keyword>Infants</keyword>
  <keyword>Atopic Dermatitis</keyword>
  <keyword>SCORAD</keyword>
  <keyword>IgE</keyword>
  <keyword>Eosinophil Cation Protein</keyword>
  <keyword>Calprotectin</keyword>
  <keyword>Intestinal microflora</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

